Merit Medical Systems Inc (MMSI)
105.33
+0.30
(+0.29%)
USD |
NASDAQ |
Nov 22, 16:00
105.39
+0.06
(+0.06%)
Pre-Market: 20:00
Merit Medical Systems Cash from Investing (Quarterly): -115.67M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -115.67M |
June 30, 2024 | -16.49M |
March 31, 2024 | -22.05M |
December 31, 2023 | -8.343M |
September 30, 2023 | -9.253M |
June 30, 2023 | -142.90M |
March 31, 2023 | -14.86M |
December 31, 2022 | -17.33M |
September 30, 2022 | -16.77M |
June 30, 2022 | -13.43M |
March 31, 2022 | -9.868M |
December 31, 2021 | -14.61M |
September 30, 2021 | -7.294M |
June 30, 2021 | -8.912M |
March 31, 2021 | -6.348M |
December 31, 2020 | -21.87M |
September 30, 2020 | -9.365M |
June 30, 2020 | -12.65M |
March 31, 2020 | -14.76M |
December 31, 2019 | -20.57M |
September 30, 2019 | -39.11M |
June 30, 2019 | -53.75M |
March 31, 2019 | -21.05M |
December 31, 2018 | -196.05M |
September 30, 2018 | -20.31M |
Date | Value |
---|---|
June 30, 2018 | -45.15M |
March 31, 2018 | -117.32M |
December 31, 2017 | -11.82M |
September 30, 2017 | -61.27M |
June 30, 2017 | -15.37M |
March 31, 2017 | -58.30M |
December 31, 2016 | -12.31M |
September 30, 2016 | -102.88M |
June 30, 2016 | -12.04M |
March 31, 2016 | -31.88M |
December 31, 2015 | -11.32M |
September 30, 2015 | -24.23M |
June 30, 2015 | -17.06M |
March 31, 2015 | -9.411M |
December 31, 2014 | -9.617M |
September 30, 2014 | -5.516M |
June 30, 2014 | -11.95M |
March 31, 2014 | -9.123M |
December 31, 2013 | -18.50M |
September 30, 2013 | -18.11M |
June 30, 2013 | -10.65M |
March 31, 2013 | -21.35M |
December 31, 2012 | -184.95M |
September 30, 2012 | -22.41M |
June 30, 2012 | -18.31M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-142.90M
Minimum
Jun 2023
-6.348M
Maximum
Mar 2021
-25.17M
Average
-14.68M
Median
Cash from Investing (Quarterly) Benchmarks
Becton Dickinson & Co | -3.937B |
Boston Scientific Corp | -1.427B |
ResMed Inc | 2.146M |
Abbott Laboratories | -594.00M |
Baxter International Inc | -164.00M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 47.33M |
Cash from Financing (Quarterly) | -47.57M |
Free Cash Flow | 172.71M |
Free Cash Flow Per Share (Quarterly) | 0.6284 |
Free Cash Flow to Equity (Quarterly) | 88.23M |
Free Cash Flow to Firm (Quarterly) | 38.07M |
Free Cash Flow Yield | 2.79% |